(800) 949-0401 Apply NowDialysis centers provide life-sustaining treatment for millions of Americans with end-stage renal disease (ESRD), but operating one requires significant capital investment in medical equipment, facility buildout, staffing, and regulatory compliance. Crestmont Capital offers specialized financing solutions for dialysis center operators -- from independent outpatient clinics to multi-location nephrology practices.
Dialysis is one of the most equipment-intensive branches of outpatient medicine. A single hemodialysis machine costs $15,000 to $30,000. A new dialysis center needs 10 to 20 stations to be operationally viable, representing $150,000 to $600,000 in equipment alone -- before factoring in the water purification systems, reverse osmosis units, and monitoring equipment that are essential for safe dialysis treatment.
Facility buildout for a new outpatient dialysis center typically costs $400,000 to $1.2 million depending on location, size, and the specific plumbing and electrical infrastructure required for dialysis operations. Annual operating costs for a 15-station center include $500,000 to $900,000 in clinical staffing, $80,000 to $150,000 in supplies, and significant regulatory compliance overhead.
The dialysis market is also growing rapidly. According to the U.S. Census Bureau, the prevalence of chronic kidney disease (CKD) affecting approximately 37 million Americans means that demand for dialysis services will continue rising for decades. Independent dialysis centers that can secure financing to expand capacity are well-positioned to capture this growing patient population.
Crestmont Capital provides medical equipment financing, working capital loans, SBA loans, and lines of credit for dialysis center operators at all stages of development.
Dialysis machines, water purification systems, patient monitoring equipment, and laboratory analyzers can all be financed through Crestmont Capital's equipment financing program. Amounts up to $500,000 per transaction with terms up to 84 months. The equipment itself serves as collateral, making approval accessible even for newer facilities. Rates start at 5.99% APR.
Managing the revenue cycle for a dialysis center is complex. Medicare reimbursements arrive 30 to 45 days after treatment. Private insurance claims may take 60 to 90 days. Meanwhile, payroll, supply costs, and facility expenses are due immediately. A working capital loan of $25,000 to $500,000 bridges these cash flow timing gaps so you never miss a payroll or fall behind on supplies.
For dialysis centers looking to open a new location or significantly expand an existing one, SBA 7(a) and 504 loans up to $5 million provide the longest terms and lowest rates available. The SBA 504 program specifically supports commercial real estate and major equipment purchases, making it ideal for dialysis facility construction and equipment.
A revolving line of credit up to $250,000 gives dialysis center managers the flexibility to handle unexpected supply shortages, emergency equipment repairs, or staffing fluctuations without disrupting patient care. Draw and repay as needed.
When a dialysis machine fails unexpectedly or a critical supply chain disruption requires an emergency purchase, fast business loans up to $150,000 are available with same-day funding for qualified applicants. Patient care cannot wait -- and neither can your financing.
Fast, flexible financing built for healthcare operators. Apply in 5 minutes.
Get My Free Quote| Requirement | Standard Loan | Fast Funding | SBA Loan |
|---|---|---|---|
| Time in Business | 6+ months | 3+ months | 2+ years |
| Monthly Revenue | $15,000+ | $8,000+ | $30,000+ |
| Credit Score | 580+ | 500+ | 650+ |
| Funding Speed | 1-3 days | Same day | 30-90 days |
| Loan Amount | $10K-$500K | $5K-$150K | Up to $5M |
| Collateral Required | Usually no | No | Yes |
An independently owned dialysis center in Memphis with 12 stations had a 6-week waitlist for new patients. Adding 6 stations required 6 new dialysis machines ($108,000), expanded water treatment capacity ($45,000), and construction work ($62,000). Total investment: $215,000. With Crestmont Capital equipment financing and a small business loan combination approved in 48 hours, the center expanded capacity, eliminated the waitlist within 90 days, and added $38,000 per month in incremental revenue.
A 20-station dialysis center in Atlanta generating $280,000 per month in revenue consistently faced a 45-day gap between treatment delivery and Medicare/Medicaid reimbursement. With $180,000 in monthly payroll and supply costs due within 30 days, cash flow was perpetually strained. A $200,000 revolving line of credit from Crestmont Capital stabilized their cash position, allowing the practice manager to focus on patient care rather than cash crisis management.
A nephrologist in Phoenix owned a successful 15-station dialysis center and identified a medically underserved zip code 8 miles away as an ideal location for a second facility. Facility build-out: $750,000. Equipment for 18 stations: $380,000. Working capital for the first 6 months of operations: $180,000. Crestmont Capital facilitated a $1.31 million SBA 7(a) loan at 7.8% APR over 10 years, with monthly payments of $15,700. The second facility reached profitability in 8 months.
A dialysis center's central water purification system failed on a Tuesday morning, rendering all 14 stations inoperable. Patient appointments had to be rerouted to a neighboring facility while emergency repairs were made. The repair and temporary rental of backup equipment cost $48,000. A fast business loan from Crestmont Capital was approved within 3 hours and funded by end of business that day, allowing all operations to resume within 72 hours.
| Product | Best For | Amount Range | Term | Speed |
|---|---|---|---|---|
| Equipment Financing | Dialysis machines/systems | $10K - $500K | 2-7 years | 1-3 days |
| Working Capital Loan | Revenue cycle gaps | $5K - $500K | 3-18 months | 24 hours |
| Line of Credit | Ongoing supply costs | $10K - $250K | Revolving | 1-2 days |
| SBA 7(a) Loan | New facility buildout | $50K - $5M | 5-25 years | 30-90 days |
| Fast Business Loan | Emergency equipment | $5K - $150K | 3-12 months | Same day |
End-stage renal disease affects over 560,000 Americans currently on dialysis, a number that grows by approximately 25,000 new patients per year. According to Bloomberg, the global dialysis market is projected to reach $115 billion by 2030, driven by rising diabetes and hypertension rates -- the two leading causes of kidney failure.
Independent dialysis centers face meaningful competition from large corporate chains, but they consistently outperform in patient satisfaction due to their ability to provide more personalized care. Independent operators who invest in modern equipment, comfortable patient environments, and transportation assistance (many dialysis patients require 3 visits per week) build loyal patient populations with extremely low attrition.
Home dialysis represents the fastest-growing segment, with peritoneal dialysis and home hemodialysis growing 8 to 12% annually as patients seek treatment options that fit their lifestyles. Dialysis centers that invest in home dialysis training programs and equipment can capture this high-growth segment without building additional facility space. Crestmont Capital finances home dialysis equipment, patient training kits, and the nursing staff costs associated with home therapy programs.
Healthcare businesses require lenders who understand the unique dynamics of medical billing, CMS reimbursement cycles, regulatory compliance costs, and the mission-critical nature of medical equipment. Crestmont Capital has financed dozens of dialysis and nephrology practices and understands what makes healthcare operators different from typical small businesses.
According to CNBC, independent healthcare providers who access capital strategically to modernize equipment and expand capacity consistently report 15 to 25% higher profit margins than those constrained by aging equipment and limited capacity.
From a single machine to a full new facility -- Crestmont Capital has the financing to make it happen.
Apply Now -- Fast Approvals for Healthcare BusinessesDialysis centers operate under one of the most heavily regulated compliance frameworks in all of outpatient medicine. Understanding these cost drivers helps operators plan their financing needs accurately:
These compliance and maintenance costs are non-negotiable for patient safety and regulatory standing. Dialysis centers that fall behind on maintenance or compliance face penalties, survey failures, and potential loss of Medicare certification -- effectively a death sentence for the business. Having a line of credit available ensures these critical costs are always funded.
Clinical staffing is typically the largest single expense for a dialysis center, representing 50 to 65% of total operating costs. Key staffing components include:
Annual staffing costs for a mid-size dialysis center can easily exceed $1.2 million. Working capital loans and lines of credit play a critical role in ensuring consistent payroll funding, particularly during the 30 to 45 day period between patient treatment and Medicare reimbursement receipt.
A dialysis center's revenue is primarily driven by the Medicare ESRD bundle payment, which as of 2024 is set at $265 per treatment. A patient receiving 3 treatments per week at 52 weeks generates approximately $41,340 in annual Medicare revenue per patient. A 15-station center running 6 days per week at 85% capacity generates approximately 2,200 treatments per month, translating to $583,000 in monthly gross revenue.
Net revenue after contractual adjustments typically runs 75 to 85% of gross billed charges. After operating expenses, well-run independent dialysis centers achieve EBITDA margins of 15 to 25% -- healthy margins that support robust loan repayment. Crestmont Capital's underwriting team is trained to evaluate dialysis center financials accurately, recognizing the difference between billed revenue and collected revenue in your loan assessment.
Disclaimer: All loan products are subject to credit approval and underwriting review. Rates, terms, and loan amounts vary based on applicant qualifications, business financials, and product type. The information on this page is for educational purposes only and does not constitute a commitment to lend. Crestmont Capital is not a bank and does not offer FDIC-insured products. SBA loans are subject to SBA eligibility requirements. Healthcare businesses should consult with compliance advisors regarding applicable regulations. Please consult with a Crestmont Capital loan advisor for personalized guidance.
